L3452021EN3910120210706EN0004391391<p xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">Corrigendum to Commission Regulation (EU) 2021/1110 of 6 July 2021 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for ametoctradin, bixafen, fenazaquin, spinetoram, tefluthrin and thiencarbazone-methyl in or on certain products</p>
<p xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">(Official Journal of the European Union L 239 of 7 July 2021)</p>On page 6, in Article 2:<p xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><!--default P | TXT -->for:</p>
<mod xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
   <quotedStructure startQuote="" endQuote="">
      <p><!--default P | TXT -->&apos;Regulation (EC) No 396/2005 as it stood before being amended by this Regulation shall continue to apply to products which were produced in the Union or imported into the Union before 27 July 2021.&apos;,</p>
   </quotedStructure>
</mod>
<p xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><!--default P | TXT -->read:</p>
<mod xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
   <quotedStructure startQuote="" endQuote="">
      <p><!--default P | TXT -->&apos;Regulation (EC) No 396/2005 as it stood before being amended by this Regulation shall continue to apply to products which were produced in the Union or imported into the Union before 27 January 2022.&apos;.</p>
   </quotedStructure>
</mod>
